DanielHLibratyMD
Infectious Disease • Worcester, MAAssociate Professor, Medicine, University Massachusetts Medical School
Are you Dr. Libraty?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Department Of Infectious Disease
Worcester, MA 01655Phone+1 508-856-4182
Summary
- Dr. Daniel Libraty, MD is an infectious disease specialist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts, California, and Colorado. He is affiliated with UMass Memorial Medical Center and is an Associate Professor at University Massachusetts Medical School.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1993 - 1996
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1989 - 1992
University of California San Diego School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 2020 - 2026
MA State Medical License 2002 - 2025
CO State Medical License 2020 - 2021- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Prospective Study of Infant Dengue Start of enrollment: 2006 Sep 01
Publications & Presentations
PubMed
- 33 citationsUnderstanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Co...Nusrat J Epsi, Stephanie A Richard, David A Lindholm, Katrin Mende, Anuradha Ganesan
Clinical Infectious Diseases. 2023-02-08 - 3 citationsAn Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.Ann I Scher, Catherine M Berjohn, Celia Byrne, Rhonda E Colombo, Christopher J Colombo
Open Forum Infectious Diseases. 2022-07-01 - 40 citationsMaternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in InfantsNatalie K. Thulin, R. Camille Brewer, Robert Sherwood, Stylianos Bournazos, Karlie Edwards
Cell Reports. 2020-05-12
Grant Support
- Mechanisms Of Vascular Leakage In Viral Hemorrhagic FeversNational Institute Of Allergy And Infectious Diseases2009–2012
- A Study Of Heterologous Immunity Induced By Neonatal BCG VaccinationNational Institute Of Allergy And Infectious Diseases2011
- A Clinical Study Of Protective And Pathogenic Immunity To Dengue During InfancyNational Institute Of Allergy And Infectious Diseases2011
- A Study Of Protective Immunity Against Dengue In InfantsNational Institute Of Allergy And Infectious Diseases2005–2009
- Hantavirus: Hemorrhagic Fever ImmunopathogenesisNational Institute Of Allergy And Infectious Diseases2008
- Cellular Immune Response To The SARS Human CoronavirusNational Institute Of Allergy And Infectious Diseases2004–2005
